Advertisement

astrazeneca

AstraZeneca to buy Britain's CAT
astrazeneca

AstraZeneca to buy Britain's CAT

Anglo-Swedish drugs giant AstraZeneca announced on Monday that it had agreed to buy Britain-based Cambridge Antibody Technology, in a deal valuing the group at 702 million pounds (9.6 billion kronor).
Profit surge for AstraZeneca
astrazeneca

Profit surge for AstraZeneca

Anglo-Swedish drugs giant AstraZeneca said on Thursday that its pre-tax profit in 2005 rose 34 percent compared with 2004 to reach 6.67 billion dollars (5.53 billion euros).
"Very good year" for Investor
astrazeneca

"Very good year" for Investor

Investor, Northern Europe's biggest industrial holding company, on Thursday announced a strong rise in earnings for 2005 as its core shareholdings staged a spectacular rally.
Astra Zeneca loses heart drug patent
astrazeneca

Astra Zeneca loses heart drug patent

The price of shares in Astra Zeneca plunged in London Wednesday after the Anglo-Swedish pharmaceutical group lost a fight to retain patent protection in the US over its top-selling heart drug Toprol XL.
AstraZeneca buys Alzheimer's drug rights
astrazeneca

AstraZeneca buys Alzheimer's drug rights

Anglo-Swedish drugs group AstraZeneca said on Wednesday it had agreed to pay up to 300 million dollars to US peer Targacept for the rights to help develop and market a drug to treat Alzheimer's disease and schizophrenia.
Swedish prosecutor to investigate Iraq bribes
astrazeneca

Swedish prosecutor to investigate Iraq bribes

The Director of Public Prosecutions, Christer van der Kwast, is to investigate claims that Swedish companies paid bribes to former Iraqi dictator Saddam Hussein's regime, in contravention of international sanctions against the country.
Rising profits for AstraZeneca
astrazeneca

Rising profits for AstraZeneca

Anglo-Swedish drugs giant AstraZeneca announced on Thursday that the company's pre-tax profit stood at $1.743 billion during the third quarter of 2005, up 23 percent from the equivalent figure last year and better than analysts' forecasts.
AstraZeneca fined 60 million euros
pfizer

AstraZeneca fined 60 million euros

The European Commission has imposed a fine of 60 million euros on Anglo-Swedish pharmaceutical giant AstraZeneca PLC for illegally pushing rivals of its stomach ulcer medicine Losec out of the market.
Profits surge for AstraZeneca
astrazeneca

Profits surge for AstraZeneca

<i>(AFP)</i> Troubled Anglo-Swedish drugs giant AstraZeneca revealed on Thursday a record 37-percent increase in pre-tax profits for the first quarter of 2005, boosted by strong sales growth and cost cutting.